Found 6 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens
PHASE1Eligible adult patients with new diagnosis of gliobastoma are enrolled to r...
Location
Multiple Locations
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PHASE1Newly diagnosed glioblastoma (GBM) patients with complete or partial surgic...
Location
The Preston Robert Tisch Brain Tumor Center at Duke
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
PHASE1The primary goal of this prospective clinical trial is to evaluate the safe...
Status
Active Not Recruiting
Location
Duke University Medical Center
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
PHASE1This is a multisite, phase I/II clinical trial in children and young adults...
Location
Washington University School of Medicine
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
PHASE1In Australia, glioblastoma (GBM) has a higher annual fatality rate than a v...
Location
Multiple Locations